Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Concert Pharmaceuticals receives FDA orphan drug designation for CTP-656 for the treatment of CF

cphi-onlineJanuary 24, 2017

Tag: Orphan Drug , cystic fibrosis

PharmaSources Customer Service